This comprehensive report contains 405 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the French coagulation testing market during the next five years.
The report explores business and technological trends in the French coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
Current and Emerging Products
Contains 405 pages and 35 tables
SIMILAR MARKET STUDIES
This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business ...
February 2017 | $8250 | View Details >>
The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ...
June 2015 | $2800 | View Details >>
2017 POC/Decentralized Clinical Chemistry and Immunodiagnostic Testing: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers-Supplier Shares and Strategies, Country Forecasts, Emerging Technologies, Instrumentation Review
VPGMarketResearch.com's new report provides a comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Rationale The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, ...
March 2017 | $0 | View Details >>
Complete report $9,800. DataPack (test volumes, sales forecasts, supplier shares) $6,400.“2015-2019 U.S. Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes ...
September 2015 | $6400 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research